Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Dec 07, 2017

---

• A Comprehensive Cancer Gene Test Gets the Go-Ahead  
  K Sheikh, Genome Magazine, Dec 4, 2017
• An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.  
  Madorsky-Feldman Dana et al. Breast cancer research and treatment 2016 Jun 157(2) 319-327
• Are Comprehensive Next-generation Sequencing Analyses Really Required for the Management of Patients With Melanoma to Date?  
  Uguen Arnaud et al. Applied immunohistochemistry & molecular morphology : AIMM 2017 Oct
• BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.  
  Lee Michelle V et al. Radiographics : a review publication of the Radiological Society of North America, Inc 37(4) 1005-1023
• CRISPR Enables Cancer Immunotherapy Drug Discovery  
  Dana Farber Blog, Nov 30, 2017
• Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.  
  Moss Haley A et al. Genetic epidemiology 2017 Nov
• Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.  
  Shin Saeam et al. Breast cancer research and treatment 2016 Aug 158(3) 433-40
• FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers,  
  FDA News Release, November 30, 2017
• Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.  
  Pectasides Eirini et al. Cancer discovery 2017 Oct
• Outcomes of retesting BRCA negative patients using multigene panels.  
  Yadav Siddhartha et al. Familial cancer 2017 Jul 16(3) 319-328